Stoughton Public Health Association Location: 10 Pearl Street, Stoughton, Massachusetts 2072 Ratings: Phone: (781) 344-7011 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Advantage Home Health Care Services Location: 1778 Washington Street, Suite 7b, Stoughton, Massachusetts 2072 Ratings:NA Phone: (781) 436-5071 Health Services: Nursing Care, Physical Therapy, Home Health Aide |
Omega Homecare Systems Inc Location: 14 Page Terrace, Suite 3b, Stoughton, Massachusetts 2072 Ratings:NA Phone: (781) 408-9066 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Home Health Aide |
Optimum Healthcare Services Llc Location: 6 Cabon Place, Suite 8, Stoughton, Massachusetts 2072 Ratings:NA Phone: (781) 961-3320 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Home Health Aide |
Creations Health Care, Inc Location: 1629 Central Street, #7, Stoughton, Massachusetts 2072 Ratings:NA Phone: (617) 435-4633 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Global Care Llc Location: 7 Cabot Place, Suite 10, Stoughton, Massachusetts 2072 Ratings:NA Phone: (774) 240-8146 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Home Health Aide |
News Archive
Protalix BioTherapeutics, Inc., announced today that the U.S. Food & Drug Administration (FDA) has accepted for review the resubmission of the taliglucerase alfa New Drug Application (NDA) following the Company's receipt of a Complete Response Letter (CRL) in February 2011.
6 Day Dental and Orthodontics now accepts Medicaid and CHIP at all five 6 Day locations – in Allen, Coppell, Frisco/Plano, Flower Mound and Roanoke/Keller.
About 40 million people contracted the flu last year, with hundreds of thousands hospitalized and 35,400 to 61,000 deaths, including 134 children, according to the Centers for Disease Control and Prevention.
New policies that eliminate sugary beverages and junk foods from schools may help slow childhood obesity, according to a San Francisco State University study released today and published in the March issue of the journal Health Affairs.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 4 days ago